Globeflex Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

Globeflex Capital’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-48,219	Closed	-$243K	–	572
2015 Q3	$243K	Buy	48,219 +21,096	+78%	+$121K	0.05%	361
2015 Q2	$174K	Sell	27,123 -18	-0.1%	-$121	0.03%	384
2015 Q1	$191K	Sell	27,141 -92,130	-77%	-$667K	0.04%	357
2014 Q4	$920K	Buy	+119,271	New	+$944K	0.18%	237
2014 Q2	–	Sell	-156,556	Closed	-$1.3M	–	751
2014 Q1	$1.3M	Sell	156,556 -1,700	-1%	-$14.6K	0.15%	166
2013 Q4	$1.33M	Sell	158,256 -300	-0.2%	-$2.53K	0.16%	160
2013 Q3	$1.26M	Hold	158,556	–	–	0.16%	172
2013 Q2	$1.22M	Buy	+158,556	New	+$1.24M	0.17%	159

Other funds holding PDLI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Globeflex Capital's PDLI Position: Q4 2015 in Review

Globeflex Capital sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 48,219 shares — an estimated $243K sold.

Globeflex Capital first reported a position in PDLI in Q2 2013 and held it in 8 quarters. The position peaked at $1.33M in Q4 2013. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

Globeflex Capital reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
Globeflex Capital sold 48,219 PDL BioPharma, Inc. shares in Q4 2015, an estimated $243K.
Globeflex Capital first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 8 quarters.
Globeflex Capital's PDL BioPharma, Inc. position peaked at $1.33M in Q4 2013.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Globeflex Capital's 13F filing for Q4 2015, filed 10 Feb 2016.